Publications by authors named "Stuart Keller"

Claim this Profile
S
Serum biomarkers associated with baricitinib response in patients with juvenile idiopathic arthritis: a post-hoc analysis of the phase 3 JUVE-BASIS trial.
Venkatesh Krishnan, Stuart Y Keller, Christine Chew, Jonathan T Sims, Ching-Yun Chang

Lancet Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of baricitinib for juvenile idiopathic arthritis associated uveitis or chronic anterior antinuclear antibody positive uveitis.
Athimalaipet V Ramanan, Catherine M Guly, Gabriele Simonini, Stuart Keller, Priyanka Sen

Arthritis Care Res (Hoboken)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population pharmacokinetic model using allometric scaling for baricitinib in patients with juvenile idiopathic arthritis.
Rodney L Decker, C Steven Ernest, David B Radtke, Rona Wang, Joana Araújo, Stuart Y Keller

CPT Pharmacometrics Syst Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS study.
Mauro Chiarito, Davide Cao, Samantha Sartori, Zhongjie Zhang, Birgit Vogel, Stuart Keller

Eur Heart J Acute Cardiovasc Care· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial.
Athimalaipet V Ramanan, Pierre Quartier, Nami Okamoto, Ivan Foeldvari, Alberto Spindler, Stuart Keller

Lancet· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microsampling in pediatric studies: pharmacokinetic sampling for baricitinib (Olumiant™) in global pediatric studies.
Enaksha R Wickremsinhe, Rodney L Decker, Lisa B Lee, Erica Lelle, Lena A Carlton, Stuart Y Keller

Bioanalysis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT).
Athimalaipet V Ramanan, Catherine M Guly, Stuart Y Keller, Douglas E Schlichting, Stephanie de Bono

Trials· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study.
Jaya Chandrasekhar, Usman Baber, Samantha Sartori, Melissa Aquino, Kamilia Moalem, Stuart Keller

Clin Res Cardiol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry.
Rishi Chandiramani, Huazhen Chen, Shunsuke Aoi, Gennaro Giustino, Bimmer Claessen, Stuart Keller

Catheter Cardiovasc Interv· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
Michela Faggioni, Usman Baber, Jaya Chandrasekhar, Samantha Sartori, William Weintraub, Stuart Keller

Catheter Cardiovasc Interv· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registry.
Zhen Ge, Usman Baber, Bimmer E Claessen, Jaya Chandrasekhar, Rishi Chandiramani, Stuart Keller

J Thromb Thrombolysis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
Zhen Ge, Usman Baber, Bimmer E Claessen, Serdar Farhan, Jaya Chandrasekhar, Stuart Keller

Catheter Cardiovasc Interv· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention.
Michela Faggioni, Usman Baber, Jaya Chandrasekhar, Samantha Sartori, Bimmer E Claessen, Stuart Keller

Int J Cardiol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database.
Mark B Effron, Kavita V Nair, Cliff Molife, Stuart Y Keller, Robert L Page

Am J Cardiovasc Drugs· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study.
Jaya Chandrasekhar, Usman Baber, Samantha Sartori, Melissa Aquino, Annapoorna S Kini, Stuart Keller

Can J Cardiol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.
Usman Baber, Jaya Chandrasekhar, Samantha Sartori, Melissa Aquino, Annapoorna S Kini, Stuart Keller

JACC Cardiovasc Interv· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study.
Usman Baber, Samantha Sartori, Melissa Aquino, Annapoorna Kini, Samir Kapadia, Stuart Keller

Am Heart J· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study.
Jaya Chandrasekhar, Usman Baber, Samantha Sartori, Michela Faggioni, Melissa Aquino, Stuart Keller

Catheter Cardiovasc Interv· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year post-discharge resource utilization and treatment patterns of patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with ticagrelor or prasugrel.
Jason C Simeone, Cliff Molife, Elizabeth Marrett, Feride Frech-Tamas, Mark B Effron, Stuart Keller

Am J Cardiovasc Drugs· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis